Close Menu

NEW YORK – Theradiag this week said that it has applied CE marking for its i-Track automated analyzer for biotherapy monitoring.

The analyzer is manufactured by UK-based Immunodiagnostic Systems for Theradiag and leverages chemiluminescence-based technology. The two companies reached a deal earlier this year giving Marne-la-Vallée, France-based Theradiag access to the platform, formerly called the iDS-i10 automation system.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.